Clinical Trial Update: Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Omacor for vascular dysfunction in patients with type 2 diabetes mellitus and atherosclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Omacor (omega-3-acid ethyl esters)

Snippet

Sponsor: Ruhr University of Bochum | Conditions: Atherosclerosis, Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED